ACB
Price
$4.88
Change
-$0.05 (-1.01%)
Updated
Sep 12, 02:30 PM (EDT)
Capitalization
276.23M
55 days until earnings call
CGC
Price
$1.38
Change
-$0.01 (-0.72%)
Updated
Sep 12, 12:23 PM (EDT)
Capitalization
432.58M
56 days until earnings call
Interact to see
Advertisement

ACB vs CGC

Header iconACB vs CGC Comparison
Open Charts ACB vs CGCBanner chart's image
Aurora Cannabis
Price$4.88
Change-$0.05 (-1.01%)
Volume$499
Capitalization276.23M
Canopy Growth
Price$1.38
Change-$0.01 (-0.72%)
Volume$6.6K
Capitalization432.58M
ACB vs CGC Comparison Chart in %
Loading...
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ACB vs. CGC commentary
Sep 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACB is a Hold and CGC is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 12, 2025
Stock price -- (ACB: $4.93 vs. CGC: $1.39)
Brand notoriety: ACB and CGC are both notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ACB: 58% vs. CGC: 60%
Market capitalization -- ACB: $276.23M vs. CGC: $432.58M
ACB [@Pharmaceuticals: Generic] is valued at $276.23M. CGC’s [@Pharmaceuticals: Generic] market capitalization is $432.58M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $66.75B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.94B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACB’s FA Score shows that 0 FA rating(s) are green whileCGC’s FA Score has 0 green FA rating(s).

  • ACB’s FA Score: 0 green, 5 red.
  • CGC’s FA Score: 0 green, 5 red.
According to our system of comparison, ACB is a better buy in the long-term than CGC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACB’s TA Score shows that 6 TA indicator(s) are bullish while CGC’s TA Score has 5 bullish TA indicator(s).

  • ACB’s TA Score: 6 bullish, 5 bearish.
  • CGC’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ACB is a better buy in the short-term than CGC.

Price Growth

ACB (@Pharmaceuticals: Generic) experienced а +2.07% price change this week, while CGC (@Pharmaceuticals: Generic) price change was +0.72% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +1.60%. For the same industry, the average monthly price growth was +4.85%, and the average quarterly price growth was +53.91%.

Reported Earning Dates

ACB is expected to report earnings on Nov 06, 2025.

CGC is expected to report earnings on Nov 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Generic (+1.60% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGC($433M) has a higher market cap than ACB($276M). ACB YTD gains are higher at: 16.000 vs. CGC (-49.270). ACB has higher annual earnings (EBITDA): 26.6M vs. CGC (-410.31M). CGC (144M) and ACB (140M) have equal amount of cash in the bank . ACB has less debt than CGC: ACB (102M) vs CGC (328M). ACB has higher revenues than CGC: ACB (358M) vs CGC (275M).
ACBCGCACB / CGC
Capitalization276M433M64%
EBITDA26.6M-410.31M-6%
Gain YTD16.000-49.270-32%
P/E Ratio19.44N/A-
Revenue358M275M130%
Total Cash140M144M97%
Total Debt102M328M31%
FUNDAMENTALS RATINGS
ACB vs CGC: Fundamental Ratings
ACB
CGC
OUTLOOK RATING
1..100
7261
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
92
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9399
PRICE GROWTH RATING
1..100
6264
P/E GROWTH RATING
1..100
92100
SEASONALITY SCORE
1..100
9044

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACB's Valuation (57) in the Pharmaceuticals Other industry is somewhat better than the same rating for CGC (92) in the Agricultural Commodities Or Milling industry. This means that ACB’s stock grew somewhat faster than CGC’s over the last 12 months.

ACB's Profit vs Risk Rating (100) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that ACB’s stock grew similarly to CGC’s over the last 12 months.

ACB's SMR Rating (93) in the Pharmaceuticals Other industry is in the same range as CGC (99) in the Agricultural Commodities Or Milling industry. This means that ACB’s stock grew similarly to CGC’s over the last 12 months.

ACB's Price Growth Rating (62) in the Pharmaceuticals Other industry is in the same range as CGC (64) in the Agricultural Commodities Or Milling industry. This means that ACB’s stock grew similarly to CGC’s over the last 12 months.

ACB's P/E Growth Rating (92) in the Pharmaceuticals Other industry is in the same range as CGC (100) in the Agricultural Commodities Or Milling industry. This means that ACB’s stock grew similarly to CGC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACBCGC
RSI
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 16 days ago
78%
Bullish Trend 16 days ago
80%
Declines
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
ACB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CGC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TCLAF14.440.04
+0.28%
Transcontinental Inc.
ABSCF1.26N/A
N/A
AB Science, Paris
PGNT4.99N/A
N/A
Paragon Technologies, Inc.
PINXF0.89N/A
N/A
Peoples Insurance Company Group China
IMDZF133.20N/A
N/A
IMCD NV

CGC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGC has been closely correlated with SNDL. These tickers have moved in lockstep 77% of the time. This A.I.-generated data suggests there is a high statistical probability that if CGC jumps, then SNDL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGC
1D Price
Change %
CGC100%
N/A
SNDL - CGC
77%
Closely correlated
+1.48%
ACB - CGC
66%
Loosely correlated
-0.80%
OGI - CGC
62%
Loosely correlated
+0.61%
TLRY - CGC
60%
Loosely correlated
-2.75%
CRON - CGC
58%
Loosely correlated
+1.98%
More